The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.
FDA Panel Recommends Pulling Preterm Birth Drug From the Market
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in